References
- de Buck, R., (1973). Clinical experience with lorazepam in the treatment of neurotic patients. Curr. med. Res. Opin., 1, 291.1. de Buck, R., (1973). Clinical experience with lorazepam in the treatment of neurotic patients. Curr. med. Res. Opin., 1, 291.
- Eaves, D., Jain, V. K., and Swinson, R. P., (1973). A double-blind controlled trial of lorazepam and diazepam in the treatment of anxiety. Curr. med. Res. Opin., 1, 265.2. Eaves, D., Jain, V. K., and Swinson, R. P., (1973). A double-blind controlled trial of lorazepam and diazepam in the treatment of anxiety. Curr. med. Res. Opin., 1, 265.
- Gluckman, M. I., (1971). Pharmacology of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam; Wy. 4036). Arzneim.-forsch., 21, 1049.3. Gluckman, M. I., (1971). Pharmacology of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam; Wy. 4036). Arzneim.-forsch., 21, 1049.
- Hamilton, M., (1959). The assessment of anxiety states by rating. Brit. J. med. Psychol., 32, 50.4. Hamilton, M., (1959). The assessment of anxiety states by rating. Brit. J. med. Psychol., 32, 50.
- Silverstone, J. T., (1973). Lorazepam in phobic disorders: a pilot study. Curr. med. Res. Opin., 1, 272.5. Silverstone, J. T., (1973). Lorazepam in phobic disorders: a pilot study. Curr. med. Res. Opin., 1, 272.